RxDoctor Payments Data

Kelsey Denning

Women's Health · Toms River, NJNPI 1619401833

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.8% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Among women's health clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,110in general payments, 2019–2025

Across 191 payments — averaging $16.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$545
  • Astellas Pharma US Inc$396
  • Mayne Pharma Commercial LLC$331
  • Exeltis, USA Inc.$308
  • Sumitomo Pharma America, Inc.$223
  • Kyowa Kirin, Inc.$143
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,01097%
  • Education$1003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,110 in reported general payments places this provider in the 95th percentile of 182 women's health providers in New Jersey.

See all women's health providers in New Jersey

Medicare billing

Part B allowed, 2024
$2,295
Medicare patients
26
Services billed
57

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol18$1,711
Clobetasol Propionate14$638
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst26$334

Paid to pharmacies, not to this prescriber.

Other women's health in Toms River

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →